General Archive
-
News releasesCEO Dave Tapolczay stepping down
Dave Tapolczay, Chief Executive Officer, LifeArc, has announced his intention to step down after 10 years in the role. Under…
-
News releasesLifeArc announces £5M support for rare disease research
LifeArc®, the medical research charity, today announced its Philanthropic Fund will award £5M in grants to support medical research projects…
-
News releasesNew partnership in artificial intelligence and machine learning for target discovery announced
New LifeArc®/Milner Therapeutics Institute partnership use machine learning to identify and validate new drug targets in immuno-oncology and respiratory diseases.
-
News releasesPartnership with TetraGenetics targets Type 1 diabetes
New partnership hopes to accelerate the development of a cure for Type 1 Diabetes.
-
News releasesLifeArc appointments strengthen board of trustees
LifeArc has strengthened its board by appointing three new trustees.
-
News releases
Tumour analysis following surgery could provide breakthrough in predicting how well cancer patients respond to drug treatment
A new platform for assessing anti-cancer drug efficacy could expedite the discovery of new cancer therapies.
-
News releases
Timur Avkiran awarded Industrial Fellowship
The Royal Commission for the Exhibition of 1851 has awarded Industrial Fellowships worth up to £80,000 to the UK’s 14…
-
News releasesSpringWorks Therapeutics launched to progress investigational therapies for patients with unmet medical needs
Four therapies could lead to new treatments for desmoid tumours, neurofibromatosis, hereditary xerocystosis and post-traumatic stress disorder.
-
News releasesLifeArc and AUTM forge international partnership to provide training for scholars in technology transfer
We have partnered with The Association of University Technology Managers (AUTM) Foundation to offer a competitive program that will provide…
-
News releases
LifeArc launches £100,000 awards – now closed
We have launched the LifeArc Translational Award for academic scientists to progress early stage drug discovery projects.
-
News releases
Juan Carlos Lopez to assist business development in North America
LifeArc has appointed Juan Carlos Lopez, founder of Haystack Science, to assist their business development activity in North America on…
-
News releases
Partnership with Metrion Biosciences to support LifeArc’s neuroscience small molecule drug discovery programme
Metrion to provide in-depth ion channel target class knowledge and assay support.